{"id":"CHEMBL1034","canonicalSmiles":"O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]","inchiKey":"KPHWPUGNDIVLNH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC SODIUM","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acoflam","Acoflam ret","Acoflam sr","Arthronac","Arthrotec 50","Arthrotec 75","Closteril 100","Defanac","Defanac retard","Defanac sr","Dexomon ret","Dexomon sr","Diclofenac sodium","Dicloflex","Dicloflex ret","Dicloflex sr","Diclomax ret","Diclomax sr","Diclotard 100 mr","Diclotard 75 mr","Diclovol","Diclovol ret","Diclovol sr","Diclozip 25","Diclozip 50","Difenor xl","Digenac xl 100","Dyloject","Econac","Econac sr","Econac xl","Enstar sr","Enstar xl","Enzed","Fenactol","Fenactol ret","Fenactol sr","Flamatak mr","Flamrase","Flamrase sr","Flexotard mr","Isclofen","Lofensaid 25","Lofensaid 50","Lofensaid ret 100","Lofensaid ret 75","Masidemen","Misofen","Mobigel","Mobigel paineze","Motifene","Pennsaid","Rheumatac ret 75","Rhumalgan","Rhumalgan cr 100","Rhumalgan cr 75","Rhumalgan sr","Rhumalgan xl","Slofenac","Solaraze","Valdic 100 ret","Valdic 75 ret","Valenac","Volraman","Volsaid ret 100","Volsaid ret 75","Voltaren","Voltaren arthritis pain","Voltaren emulgel","Voltaren ret","Voltaren-xr","Voltarene","Voltarene emulgel","Voltarene l.p.","Voltarene ret","Voltarol","Voltarol 12 hour emulgel p","Voltarol active","Voltarol emulgel","Voltarol emulgel p","Voltarol gel patch","Voltarol ophtha","Voltarol pain-eze emulgel","Voltarol ret","Voltarol sr"],"synonyms":["Abitren","Benfofen","Dealgic","Deflamat","Delphinac","Diclofenac diethylamine","Diclofenac diethylamine salt","Diclofenac diethylammonium","Diclofenac diethylammonium salt","Diclofenac sod","Diclofenac sodium","Diclofenac sodium salt","Diclomax","Diclophenac sodium","Diclophlogont","Dicloreum","Duravolten","Ecofenac","Effekton","GP 45840","GP-45840","Lexobene","NSC-756725","Neriodin","Novapirina","Primofenac","Prophenatin","Rewodina","Sodium diclofenac","Voldal","Xenid"],"crossReferences":{"DailyMed":["diclofenac%20sodium"],"PubChem":["11111091","11112998","144204321","144210585","170464642","26747983","50106220","56422389","85231008","855544","90341049"],"chEBI":["4509"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0021440","EFO_0000685","EFO_0002970","HP_0012532","EFO_0009816","EFO_0004274","EFO_0010072","MONDO_0002959","EFO_0003958","EFO_0003843","EFO_0002496","MONDO_0001187","MP_0001914","EFO_1001412","MP_0001845","MONDO_0100096","EFO_0009560","EFO_0009582","EFO_0004616","EFO_0004272","HP_0100607","HP_0003419","EFO_0005611","EFO_0009321","MONDO_0005178"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 4 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL108358","canonicalSmiles":"NC(=O)c1csc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1","inchiKey":"FVRDYQYEVDDKCR-DBRKOABJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAZOFURIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-909","NSC-286193","Riboxamide","Tiazofurin","Tiazofurine"],"crossReferences":{"Wikipedia":["Tiazofurin"],"drugbank":["DB13243"],"chEBI":["90239"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1089221","canonicalSmiles":"O=C(O)COc1nn(Cc2ccccc2)c2ccccc12","inchiKey":"BYFMCKSPFYVMOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAZAC","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"],"classes":["Hepatotoxicity"],"year":1993},"tradeNames":[],"synonyms":["AF 1934 [LYSINE]","Bendazac","Bindazac","Iwazac"],"crossReferences":{"PubChem":["50112715"],"TG-GATEs":["129"],"Wikipedia":["Bendazac"],"drugbank":["DB13501"],"chEBI":["31257"]},"childChemblIds":["CHEMBL3189046","CHEMBL1089222"],"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005752"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 3 approved indications. It was withdrawn in Spain  in 1993 due to Hepatotoxicity."}
{"id":"CHEMBL113644","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC","inchiKey":"NRJAVPSFFCBXDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113644","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1140","canonicalSmiles":"NC(=O)c1cccnc1","inchiKey":"DFPAKSUCGFBDDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIACINAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Freederm","Niatin","Nicam","Nicobion","Papulex"],"synonyms":["NSC-13128","NSC-27452","Niacin (as niacinamide)","Niacinamid","Niacinamide","Nicotinamide","Nicotinamidum","Nicotinic acid amide","Nicotylamide"],"crossReferences":{"PubChem":["144204753","144208914","144213093","170464905","174007286","29215143","8139965"],"Wikipedia":["Nicotinamide"],"drugbank":["DB02701"],"chEBI":["17154"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 approved and 27 investigational indications."}
{"id":"CHEMBL1172560","canonicalSmiles":"O=C(O)CCc1ccc(O)cc1","inchiKey":"NMHMNPHRMNGLLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYPHENYL PROPIONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(4-Hydroxyphenyl)Propanoic Acid","4-Hydroxybenzylacetic Acid"],"crossReferences":{"drugbank":["DB03897"],"chEBI":["32980"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1191","canonicalSmiles":"Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1","inchiKey":"VACCAVUAMIDAGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETHIZOLE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methazol","Microsul","Proklar","Sulphamethylthiadiazole","Tetracid","Thiosulfil","Urolucosil"],"synonyms":["NSC-757327","Sulfamethizole","Sulphamethizole"],"crossReferences":{"PubChem":["11112301","144203976","144208233","170465369","17389528","856011"],"Wikipedia":["Sulfamethizole"],"drugbank":["DB00576"],"chEBI":["9331"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for bacterial disease and eye infection and has 1 investigational indication."}
{"id":"CHEMBL1199307","canonicalSmiles":"CN(CCCCCCN(C)C(=O)Oc1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1","inchiKey":"AHZBEVXBKNYXPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DISTIGMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Distigmine","Distigmine cation","Distigmine ion"],"crossReferences":{"drugbank":["DB13694"],"chEBI":["80756"]},"childChemblIds":["CHEMBL1098285"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200418","canonicalSmiles":"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl","inchiKey":"BQKADKWNRWCIJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOBUTAMINE HYDROCHLORIDE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL926","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dobutamine hydrochloride","Dobutrex","Posiject"],"synonyms":["46236","Dl-dobutamine hydrochloride","Dobutamine hcl","Dobutamine hydrochloride","NSC-299583"],"crossReferences":{"PubChem":["46500392","50106131","50106132","56320684"],"chEBI":["4671"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000373","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for congestive heart failure and has 1 investigational indication."}
{"id":"CHEMBL1200482","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O.[Na+]","inchiKey":"NCFTXMQPRQZFMZ-WERGMSTESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOPERAZONE SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL507674","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefobid","Cefobis"],"synonyms":["CP-52,640-2","CP-52640-2","CP-526402","Cefoperazone (as sodium)","Cefoperazone sodium","Cefoperazone sodium salt","NSC-758173","Sodium cefoperazone","T-1551"],"crossReferences":{"PubChem":["144204920","170465235"],"chEBI":["3494"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1200654","canonicalSmiles":"CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N.Cl","inchiKey":"PRGUDWLMFLCODA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENOXINATE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benoxinate hydrochloride"],"synonyms":["Benoxinate hcl","Benoxinate hydrochloride","NSC-759847","Oxibuprocaine chloride","Oxybuprocaine hcl","Oxybuprocaine hydrochloride"],"crossReferences":{"DailyMed":["benoxinate%20hydrochloride"],"PubChem":["144204104","170464771","56463336"],"chEBI":["31260"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200703","canonicalSmiles":"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1.Cl","inchiKey":"DMLFJMQTNDSRFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORDIAZEPOXIDE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL451","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-poxide","Chlordiazachel","Chlordiazepoxide hydrochloride","Librium","Lygen","Tropium"],"synonyms":["Chlordiazepoxide hcl","Chlordiazepoxide hydrochloride","Clopoxide chloride","NSC-115748","RO 5-0690","RO-5-0690"],"crossReferences":{"DailyMed":["chlordiazepoxide%20hydrochloride"],"chEBI":["3612"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201012","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"POPFMWWJOGLOIF-XWCQMRHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLURANDRENOLIDE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cordran","Cordran sp","Flurandrenolide","Haelan","Haelan-c","Haelan-x"],"synonyms":["33379","Fludroxicortide","Fludroxycortide","Flurandrenolide","Flurandrenolone","NSC-757869"],"crossReferences":{"DailyMed":["flurandrenolide"],"PubChem":["144204060","144212928","170465298","56424122","855862"],"Wikipedia":["Fludroxycortide"],"drugbank":["DB00846"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_0000701"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for skin disease and has 1 investigational indication."}
{"id":"CHEMBL1201146","canonicalSmiles":"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"IMONTRJLAWHYGT-ZCPXKWAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORETHINDRONE ACETATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aygestin","Norethidrone Acetate","Norethindrone acetate","Norlutate"],"synonyms":["NSC-22844","Norethindrone acetate","Norethisteron acetate","Norethisterone 17-acetate","Norethisterone acetate","Norethisteroni acetas","Norethynyltestosterone","Norlutin acetate","SH-420"],"crossReferences":{"DailyMed":["norethindrone%20acetate"],"PubChem":["144206922","29215468"],"Wikipedia":["Norethisterone_acetate"],"chEBI":["7628"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0001065","MONDO_0007254","Orphanet_586","EFO_0003894","EFO_0003843","EFO_0002950","MP_0001914","MONDO_0002146","MONDO_0041161","EFO_0000731","HP_0000138","HP_0008209","EFO_0000574","EFO_0003922"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 8 investigational indications."}
{"id":"CHEMBL1201301","drugType":"Small molecule","blackBoxWarning":false,"name":"MANGAFODIPIR","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mangafodipir"],"crossReferences":{"DrugCentral":["4532"]},"childChemblIds":["CHEMBL2096651"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 3 investigational indications."}
{"id":"CHEMBL1201327","canonicalSmiles":"CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"GNOGSFBXBWBTIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETRIZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetrizoate","Acetrizoic Acid","Acetrizoic acid","NSC-758681","Urokonic acid"],"crossReferences":{"PubChem":["144204976","170465154","26748914"],"Wikipedia":["Acetrizoic_acid"],"drugbank":["DB09347"],"chEBI":["34521"]},"childChemblIds":["CHEMBL1201045"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201634","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PURIFIED BEEF/PORK","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lentard"],"synonyms":["Insulin zinc susp purified beef/pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201662","drugType":"Protein","blackBoxWarning":true,"name":"DESIRUDIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iprivask"],"synonyms":["63-desulfohirudin","63-desulfohirudin (recombinant)","CGP 39393","CGP-39393","Desirudin","Desirudin recombinant","Hirudin desirudin","Revasc"],"crossReferences":{"DrugCentral":["2990"]},"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["MONDO_0000831","EFO_0003907","HP_0004419","HP_0001873"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for deep vein thrombosis and recurrent thrombophlebitis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201773","canonicalSmiles":"CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2.Cl","inchiKey":"JALHGCPDPSNJNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PRASUGREL HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201772","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Effient"],"synonyms":["LY640315","Prasu doc","Prasugrel hcl","Prasugrel hydrochloride"],"crossReferences":{"DailyMed":["prasugrel%20hydrochloride"],"PubChem":["144207170","170465441"]},"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0000612","EFO_0005672"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201825","drugType":"Antibody","blackBoxWarning":false,"name":"RANIBIZUMAB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lucentis"],"synonyms":["BCD-300","FAB-12 VARIANT Y0317","PF-582","Pf-582 (ranibizumab biosimilar)","Pf582","QL-1205","QL1205","RG-3645","RHUFAB","Ranibizumab","Ranibizumab biosimilar pf582","SB-11","SB11 (RANIBIZUMAB BIOSIMILAR)"],"crossReferences":{"DailyMed":["ranibizumab"],"DrugCentral":["4971"],"Wikipedia":["Ranibizumab"]},"linkedTargets":{"rows":["ENSG00000112715"],"count":1},"linkedDiseases":{"rows":["MONDO_0001576","EFO_1001060","EFO_0004190","MONDO_0003005","EFO_0004683","EFO_0007310","EFO_0001365","EFO_1000809","HP_0000545","Orphanet_790","EFO_0005753","EFO_0009322","EFO_0005773","EFO_0009760","EFO_0009606","EFO_1000880","Orphanet_892","MONDO_0002175","EFO_0009093","EFO_0003839","EFO_0009321","EFO_0000400","MONDO_0001941","EFO_1000616","EFO_0004207","EFO_1001157","EFO_0003770","EFO_1002009","EFO_0009784","EFO_1000805","Orphanet_624","EFO_0000678","EFO_0009363","Orphanet_98616","EFO_0000516","EFO_1001158"],"count":36},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 24 investigational indications."}
{"id":"CHEMBL1213083","canonicalSmiles":"COc1ccccc1-n1c(CSc2ncnc3[nH]cnc23)nc2cccc(Cl)c2c1=O","inchiKey":"UMMYTDJYDSTEMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213083","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229767","canonicalSmiles":"COCCOCCOCCOCCOCCO","inchiKey":"SLNYBUIEAMRFSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229767","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211789"],"drugbank":["DB02042"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231574","canonicalSmiles":"CN1c2c([nH]c(N)nc2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"ZNOVTXRBGFNYRX-STQMWFEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEFOLIC ACID","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bodyfolin","Metafolin","Nutrifolin"],"synonyms":["(6s)-5-methyltetrahydrofolate","5- methyltetrahydrofolate","5-mthf","L-5-mthf","L-methylfolate","LMSR","Levomefolate","Levomefolic acid","Levomefolinic acid"],"crossReferences":{"DailyMed":["levomefolate%20calcium"],"drugbank":["DB11256"],"chEBI":["15641"]},"childChemblIds":["CHEMBL1615371"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for acne and iron deficiency anemia and has 1 investigational indication."}
{"id":"CHEMBL1231605","canonicalSmiles":"c1ccc(Nc2c[nH]c3ncccc23)cc1","inchiKey":"CQFGXDQUQWRXLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231605","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07524"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231801","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(N/C=N\\O)n2)s1","inchiKey":"OVKZTPFHUYGZBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26728034"],"drugbank":["DB04101"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231862","canonicalSmiles":"CC1(C)O[C@]2(C)CC[C@H]1CC2","inchiKey":"WEEGYLXZBRQIMU-WAAGHKOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231862","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03852"],"chEBI":["27961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232416","canonicalSmiles":"CC(C(=O)O)C(=O)O","inchiKey":"ZIYVHBGGAOATLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLMALONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57260769"],"drugbank":["DB04183"],"chEBI":["30860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236482","canonicalSmiles":"Cc1ncsc1CCO","inchiKey":"BKAWJIRCKVUVED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236482","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212504"],"drugbank":["DB02969"],"chEBI":["17957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237026","drugType":"Protein","blackBoxWarning":false,"name":"TESAMORELIN","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["TH-9507","TH9507","Tesamorelin"],"crossReferences":{"DrugCentral":["4170"]},"childChemblIds":["CHEMBL2111290"],"linkedTargets":{"rows":["ENSG00000106128"],"count":1},"linkedDiseases":{"rows":["HP_0100543","EFO_0000764","EFO_0000341","EFO_1001348","MONDO_0005148"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for hiv-associated lipodystrophy syndrome and has 5 investigational indications."}
{"id":"CHEMBL1254025","canonicalSmiles":"CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1","inchiKey":"OLUJSZLBWZWGJT-HGBKYHTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOLASIBAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Erlosiban","Nolasiban"],"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0000545"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1255739","canonicalSmiles":"CN(C)CCN(Cc1cccs1)c1ccccn1.Cl","inchiKey":"BONORRGKLJBGRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAPYRILENE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1411979","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"],"classes":["Carcinogenicity"],"year":1979},"tradeNames":["Thenylene hydrochloride"],"synonyms":["Methapyrilene hcl","Methapyrilene hydrochloride","NSC-758410","Thenylpyramine hydrochloride"],"crossReferences":{"PubChem":["11533035","144204808","144208332","170465531","26747593","50106697","56422381"],"chEBI":["38213"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States and  Germany initially in 1979 due to Carcinogenicity."}
{"id":"CHEMBL1269258","canonicalSmiles":"CC(C)N(Cc1ccccc1)C(=O)CN1C(=O)[C@@H](Cc2c[nH]c3ccccc23)c2nnc(-c3ccccc3)n2-c2ccccc21","inchiKey":"UBNMGTSDHSQBEL-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CE-326597","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CE-326,597","Ce-326,597","Ce-326597"],"crossReferences":{"drugbank":["DB12694"]},"linkedTargets":{"rows":["ENSG00000163394"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1311","canonicalSmiles":"O=[N+]([O-])O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12","inchiKey":"YWXYYJSYQOXTPL-SLPGGIOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSORBIDE MONONITRATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angeze 10","Angeze 20","Angeze 40","Angeze sr 40","Angeze sr 60","Angitate","Astrodur mr","Carmil xl","Chemydur 60 xl","Cibral 10","Cibral 20","Cibral 40","Cibral xl 60","Dynamin","Dynamin xl 25","Dynamin xl 50","Elantan 10","Elantan 20","Elantan 40","Elantan la 25","Elantan la 50","Eumon 40 xl","Eumon 60 xl","Imdur","Imo la","Isib 20","Isib 40","Isib 50 xl","Isib 60 xl","Ismo","Ismo 10","Ismo 20","Ismo 40","Ismo ret","Isodur","Isodur 25 xl","Isodur 50 xl","Isosorbide mononitrate","Isotard 25 xl","Isotard 40 xl","Isotard 50 xl","Isotard 60 xl","Isotrate","Ketanodur","Mcr 50","Modisal 40 xl","Modisal 60 xl","Modisal la 25","Modisal la 50","Monigen xl 60","Monit","Monit ls","Monit sr","Monit xl 60","Mono-cedocard 10","Mono-cedocard 20","Mono-cedocard 40","Monodur","Monoket","Monomax sr 40","Monomax sr 60","Monomax xl","Monomil xl","Monosorb xl 60","Pertil ret","Phasonit la 50","Relosorb xl","Slomon xl 60","Tardisc xl","Tenkosorb","Trangina xl","Vasotrate 60 sr","Xismox xl 60","Zemon 40 xl","Zemon 60 xl","Ziotan xl"],"synonyms":["1,1-diureidisobutane","AHR-4698","BM 22.145","BM 22.145IS 5-MNAHR-4698","BM-22-145","BM-22.145","BM-22145","Corangin","Diluted isosorbide mononitrate","IS 5-MN","IS-5-MN","IS-5MN","Iso-5-mononitrate","Isobutyldiurea","Isobutylenediurea","Isosorbide 5-mononitrate","Isosorbide 5-nitrate","Isosorbide dinitrate isosorbide-5-mononitrate","Isosorbide mononitrate","Isosorbide-5-mononitrate","Monocord","NSC-758619"],"crossReferences":{"DailyMed":["isosorbide%20mononitrate"],"PubChem":["144205134"],"Wikipedia":["Isosorbide_mononitrate"],"drugbank":["DB01020"],"chEBI":["6062"]},"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["HP_0012390","MP_0001914","EFO_0007401","HP_0001788","EFO_0003144","EFO_0001645","EFO_0000712","EFO_0000319","EFO_0004264","EFO_0000537","EFO_0003913"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL1389","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"WWYNJERNGUHSAO-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVONORGESTREL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Athentia next","Emerres","Emerres una","Ezinelle","Fallback solo","Her style","Isteranda","Jadelle","Jaydess","Kyleena","Levonelle","Levonelle one step","Levonelle-2","Levonorgestrel","Levosert","Liletta","Microval","Mirena","Norgeston","Norplant","Norplant Ii","Norplant System","Opcicon one-step","Ovrette","Plan B","Plan b one-step","Postinor-2","Skyla","Upostelle"],"synonyms":["BAY86-5028","Levonorgestrel","Levonorgestrelum","NSC-744007","Norgestrel (-)-form","Norgestrel, (-)-","WY-5104"],"crossReferences":{"DailyMed":["levonorgestrel"],"PubChem":["11532896","144205146","144210070","144213960","170465033","26719646","29215264","56422866"],"Wikipedia":["Levonorgestrel","Norgestrel"],"drugbank":["DB00367"],"chEBI":["6443"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0005232","EFO_0001075","EFO_0001065","EFO_1001249","EFO_0004230","HP_0000132","HP_0031217","EFO_0002950","MONDO_0005277","HP_0000938","MONDO_0041161","EFO_0000474","EFO_0000400","EFO_0004215","EFO_0000765","EFO_0000545","EFO_1001757","EFO_0000180","EFO_0001073","EFO_0003843","EFO_0004239","EFO_0000311","MP_0001914","MP_0001845","EFO_0004220","EFO_0000095","EFO_0000764","MONDO_0011962","HP_0100607","MONDO_0005148"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for menorrhagia and has 18 investigational indications."}
{"id":"CHEMBL1427","canonicalSmiles":"O=c1[nH]cnc2nc[nH]c12","inchiKey":"FDGQSTZJBFJUBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYPOXANTHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hypoxanthine"],"crossReferences":{"PubChem":["144205064","170466739","26749634"],"Wikipedia":["Hypoxanthine"],"drugbank":["DB04076"],"chEBI":["17368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1602127","canonicalSmiles":"CC(/C=C/C=C(C)/C=C/C(=O)O)=C\\C=C\\C=C(C)\\C=C\\C=C(C)\\C=C\\C(=O)O","inchiKey":"ZVKOASAVGLETCT-UOGKPENDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1602127","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["17388846"],"drugbank":["DB15201"],"chEBI":["7623"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1622638","canonicalSmiles":"Cc1cc2nc3ccc(N(C)C)cc3[s+]c2cc1N","inchiKey":"RQNADZJRELIICT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLONIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tolonium cation","Tolonium ion"],"crossReferences":{"PubChem":["50126324"],"chEBI":["87648"]},"childChemblIds":["CHEMBL1790006"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1697753","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)O.NCCCCC(N)C(=O)O","inchiKey":"JJBCTCGUOQYZHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPIRIN DL-LYSINE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL25","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetylsalicylate lysine","Acetylsalicylic acid lysinate","Aspegic","Aspidol","Aspirin dl-lysine","Aspirin lysine","Aspirisine","Dl-lysine acetylsalicylate","Dl-lysine-acetylsalicylate","Egicalm","Flectadol","L-lysine acetylsalicylate","Laspal","Lysine Acetylsalicylate","Lysine acetylsalicylate","Solpirin","Venopirin","Vetalgine"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1800807","canonicalSmiles":"COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C","inchiKey":"MZZLGJHLQGUVPN-HAWMADMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANACETRAPIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anacetrapib","MK-0859","MK0859"],"crossReferences":{"Wikipedia":["Anacetrapib"],"drugbank":["DB06630"]},"linkedTargets":{"rows":["ENSG00000087237"],"count":1},"linkedDiseases":{"rows":["HP_0003124","MONDO_0021187","EFO_0001645","Orphanet_391665","EFO_0000319","EFO_0004911","Orphanet_309005"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL181932","canonicalSmiles":"O=C(O)c1nc(=O)[nH]c(=O)[nH]1","inchiKey":"RYYCJUAHISIHTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTERACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-azaorotic acid","Allantoxanic acid","Oteracil","Oxonic acid"],"crossReferences":{"PubChem":["29217994"],"drugbank":["DB03209"],"chEBI":["30863"]},"childChemblIds":["CHEMBL3184847"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 32 investigational indications."}
{"id":"CHEMBL1908377","canonicalSmiles":"Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.O=C([O-])c1cc2ccccc2c(Cc2c(O)c(C(=O)[O-])cc3ccccc23)c1O","inchiKey":"OOPDAHSJBRZRPH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRVINIUM PAMOATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201303","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Poquil","Povan","Vanquil","Vanquin","Viprynium Embonate"],"synonyms":["NSC-223622","Pyrvinium (as embonate)","Pyrvinium embonate","Pyrvinium pamoate","Viprynium embonate"],"crossReferences":{"PubChem":["144204304"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL194911","canonicalSmiles":"COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1","inchiKey":"FGZIONRFHVNRJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194911","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124349961"],"drugbank":["DB04727"]},"childChemblIds":["CHEMBL1909396"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2051960","canonicalSmiles":"CN1CC(O)C2=C/C(=N/NC(N)=O)C(=O)C=C21","inchiKey":"XSXCZNVKFKNLPR-SDQBBNPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBAZOCHROME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrenochrome monosemicarbazone","Adrenochrome semicarbazone","Carbazochrome","NSC-73742"],"crossReferences":{"PubChem":["144206711"],"drugbank":["DB09012"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104979","canonicalSmiles":"FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F","inchiKey":"KAVGMUDTWQVPDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFLUBUTANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AI-700","Perflubutane","Sonazoid"],"crossReferences":{"drugbank":["DB12821"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2105231","canonicalSmiles":"CCOC(=O)/C=C1\\SC(N2CCCCC2)C(=O)N1CC","inchiKey":"UAXYBJSAPFTPNB-KHPPLWFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPROZOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Probkin"],"synonyms":["Coleflux","Epsyl","GO 919","GO-919","NSC-300622","Piprozolin","Probilin","Secrebil","W 3699","W 3699GO 919","W-3699"],"crossReferences":{"drugbank":["DB13202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105477","canonicalSmiles":"COc1cc(C(=O)Nc2c(Br)cc(Br)cc2CN(C)C2CCCCC2)ccc1OC(C)=O","inchiKey":"DQTRREPKGJIABH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROVANEXINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bronquimucil","Brovanexine"],"crossReferences":{"drugbank":["DB14720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107361","canonicalSmiles":"Cc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)sc1CC[C@@H]1CNc2nc(N)[nH]c(=O)c2C1","inchiKey":"QXOPTIPQEVJERB-JQWIXIFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PELITREXOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-2037","AG2037","Pelitrexol"],"crossReferences":{"drugbank":["DB12757"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108040","drugType":"Protein","blackBoxWarning":false,"name":"MIROCOCEPT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APT 070","APT-070","Mirococept"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108042","drugType":"Antibody","blackBoxWarning":false,"name":"PAGIBAXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A110","BSYX-A110","Pagibaximab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108334","drugType":"Protein","blackBoxWarning":false,"name":"EPTACOG ALFA (ACTIVATED)","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Eptacog alfa (activated)","Eptacog beta (activated)","LR-769","LR769"],"crossReferences":{"DrugCentral":["5159"]},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109393","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7160","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7160"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109469","drugType":"Antibody","blackBoxWarning":false,"name":"AFASEVIKUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afasevikumab","MCAF-5352A","MCAF5352A","NI-1401","RG-7624","RG7624","RO-5553110","RO5553110"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111084","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C","inchiKey":"LNHWXBUNXOXMRL-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELOTECAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Belotecan"],"crossReferences":{"drugbank":["DB12459"]},"childChemblIds":["CHEMBL2107315"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002974","MONDO_0008170","MONDO_0008903","EFO_0000702","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL248702","canonicalSmiles":"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1","inchiKey":"DBGIVFWFUFKIQN-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXFENFLURAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," European Union"," Canada"," Malasia"," India"," Saudi Arabia"],"classes":["Cardiotoxicity"],"year":1997},"tradeNames":[],"synonyms":["D-fenfluramine","Dexfenfluramine","Fenfluramine d-form","Isolipan","J13.711A","S 5614"],"crossReferences":{"Wikipedia":["Dexfenfluramine"],"drugbank":["DB01191"],"chEBI":["439329"]},"childChemblIds":["CHEMBL1887891"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000164270","ENSG00000168830","ENSG00000102468","ENSG00000157219","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000148680","ENSG00000147246","ENSG00000135312","ENSG00000135914","ENSG00000179546","ENSG00000149305","ENSG00000158748","ENSG00000179097","ENSG00000166736"],"count":17},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for obesity. It was withdrawn in United Kingdom,  United States,  European Union,  Canada,  Malasia,  India and  Saudi Arabia initially in 1997 due to Cardiotoxicity."}
{"id":"CHEMBL24957","canonicalSmiles":"CC[C@H](CO)NC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC)cc12","inchiKey":"GKJWXEORYGBJFS-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL24957","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07981"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259850","canonicalSmiles":"COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1","inchiKey":"YAEMHJKFIIIULI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-A014418","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-A014418"],"crossReferences":{"PubChem":["103904634"],"drugbank":["DB01950"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL266510","canonicalSmiles":"COc1ccc(Cl)cc1[C@]1(F)C(=O)Nc2cc(C(F)(F)F)ccc21","inchiKey":"ULYONBAOIMCNEH-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLINDOKALNER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Maxipost"],"synonyms":["BMS-204352","BMS-204352-01","Flindokalner"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL274536","canonicalSmiles":"NC(=O)c1ncn([C@H]2O[C@@H](CO)[C@H](O)[C@@H]2O)n1","inchiKey":"IWUCXVSUMQZMFG-RGDLXGNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL274536","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06523"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279786","canonicalSmiles":"CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc1cccs1)C(=O)NO","inchiKey":"XFILPEOLDIKJHX-QYZOEREBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATIMASTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-94","Batimastat"],"crossReferences":{"drugbank":["DB03880"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286796","canonicalSmiles":"CCOC(=O)/C=C/c1ccc(O)c(OC)c1","inchiKey":"ATJVZXXHKSYELS-FNORWQNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL FERULATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethyl Ferulate"],"crossReferences":{"drugbank":["DB11285"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305187","canonicalSmiles":"CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1","inchiKey":"UYNVMODNBIQBMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IFENPRODIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vadilex"],"synonyms":["Ifenprodil","Ifenprodil hemitartrate","Ifenprodil tartrate","NP-120","RC 61-91","RC-61-91"],"crossReferences":{"PubChem":["144204466","170465791","26751765","29215029","50104451","50104452","90341159"],"drugbank":["DB08954"]},"childChemblIds":["CHEMBL1372983","CHEMBL1256662","CHEMBL1886888","CHEMBL1597876"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL3182744","canonicalSmiles":"CC1=C(C(=O)O)N2C(=O)[C@@H](N)[C@H]2SC1","inchiKey":"NVIAYEIXYQCDAN-CLZZGJSISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182744","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170466755"],"drugbank":["DB14107"],"chEBI":["64984"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187032","canonicalSmiles":"O=C1C(N(CO)C(=O)NCO)N(CO)C(=O)N1CO","inchiKey":"SOROIESOUPGGFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187032","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209266","144213680"],"drugbank":["DB14173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL321582","canonicalSmiles":"CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N","inchiKey":"FBMYKMYQHCBIGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCINDOLOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bucindolol"],"crossReferences":{"PubChem":["144206141","170466320","50112957"],"drugbank":["DB12752"]},"childChemblIds":["CHEMBL2107546"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591"],"count":5},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL323542","canonicalSmiles":"CCSC(=N)Nc1ccc(C(F)(F)F)cc1","inchiKey":"LCMOXIFARISMOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323542","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111911"],"drugbank":["DB02991"]},"childChemblIds":["CHEMBL542855"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3259907","canonicalSmiles":"Cc1nc2ccccc2c(-c2ccc3c4c(ccnc24)CCO3)c1[C@H](OC(C)(C)C)C(=O)O","inchiKey":"MIXIIJCBELCMCZ-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI 224436","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi 224436"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301573","drugType":"Cell","blackBoxWarning":false,"name":"DORGENMELTUCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hyperacute-melanoma"],"synonyms":["Dorgenmeltucel-l","HAM","NLG-12036"],"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL33103","canonicalSmiles":"CC(=O)NCCc1c[nH]c2ccc(O)cc12","inchiKey":"MVAWJSIDNICKHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLSEROTONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Acetylserotonin"],"crossReferences":{"PubChem":["11110718","124879115","26747425","26753507","46500457","50105763","85230897","90341149"],"Wikipedia":["N-Acetylserotonin"],"drugbank":["DB04275"],"chEBI":["17697"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3416885","canonicalSmiles":"CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21","inchiKey":"QZXVLRCMAHJVIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-5028442","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO5028442","Ro-5028442","Ro5028442"],"crossReferences":{"drugbank":["DB12721"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544953","drugType":"Small molecule","blackBoxWarning":false,"name":"SAF312","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saf312"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["HP_0200026","HP_0000011","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545003","drugType":"Small molecule","blackBoxWarning":false,"name":"MSC-2363318A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-2698","M2698","MSC-2363318A","MSC2363318A","Msc-2363318a"],"linkedTargets":{"rows":["ENSG00000175634","ENSG00000117020","ENSG00000108443","ENSG00000142208"],"count":4},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545093","drugType":"Small molecule","blackBoxWarning":false,"name":"ZYH7","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zyh7"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0004211","Orphanet_309005"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545296","drugType":"Small molecule","blackBoxWarning":false,"name":"ARQ-736","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARQ-736","Arq 736","Arq-736"],"linkedTargets":{"rows":["ENSG00000157764","ENSG00000132155"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545334","drugType":"Small molecule","blackBoxWarning":false,"name":"AVE8134","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ave8134"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545385","drugType":"Small molecule","blackBoxWarning":false,"name":"WX-037","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Wx-037"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL356362","canonicalSmiles":"C=C(C)CCOP(=O)(O)OP(=O)(O)O","inchiKey":"NUHSROFQTUXZQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPENTENYLPYROPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isopentenyl Pyrophosphate","Isopentenylpyrophosphate"],"crossReferences":{"drugbank":["DB04714"],"chEBI":["16584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3633802","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc(-c3ccccc3)nn2)n(C)c1=O","inchiKey":"QTRXIFVSTWXRJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETC-159","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etc-159","Etc-1922159"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707254","canonicalSmiles":"O=C1CN(/N=C/C=C/c2ccc([N+](=O)[O-])o2)C(=O)N1","inchiKey":"DECBQELQORZLLP-UAIOPKHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURAZIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Akritoin","Furagin","Furaginum","Furazidin","Furazidine"],"crossReferences":{"drugbank":["DB13475"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707334","canonicalSmiles":"O[B-]1(O)OO[B-](O)(O)OO1","inchiKey":"PNIJRIIGBGFYHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERBORIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Perboric acid (hbo(o2))","Perboric acid (hbo3)"],"childChemblIds":["CHEMBL3707333"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL3746329","canonicalSmiles":"O=C(O)C1(Sc2ccnc3ccc(Br)cc23)CCC1","inchiKey":"QGBWIYLNOBYNDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SHR-4640","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ruzinurad","SHR-4640","SHR4640","Shr-4640","Shr4640"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3988900","canonicalSmiles":"[O-2].[Zn+2]","inchiKey":"RNWHGQJWIACOKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC OXIDE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anusol","Curash","Dr.elsoms","Pate a l'eau","Polano's","Sudocrem","Z.e.b.","Zinc Oxide","Zn co"],"synonyms":["C.i. 77947","C.i. pigment white 4","Ci 77947","Zinc (as oxide)","Zinc (as zinc oxide)","Zinc oxide","Zinc oxide emulsion","Zinc oxide neutral","Zinc paste","Zinc white","Zinci oxydum","Zincum oxydatum"],"crossReferences":{"DailyMed":["zinc%20oxide"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 17 approved and 1 investigational indication."}
{"id":"CHEMBL3989911","canonicalSmiles":"CC(O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCNC(=O)CCCN(CC(N)=O)C(=O)[C@H](Cc2ccccc2)NC1=O","inchiKey":"ABFNTRQPWNXUHA-NNIYEDDKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VELDOREOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COR-005","DG-3173","DG3173","Dg3173","PTR 3173","PTR-3173","Somatoprim","Veldoreotide"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000180616"],"count":3},"linkedDiseases":{"rows":["EFO_1001485"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989929","canonicalSmiles":"CCCCc1nc(-c2ccc(OCCCN(CC)CC)cc2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1","inchiKey":"KJNNWYBAOPXVJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELIRAGON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azeliragon","PF-04494700","TTP-488","TTP448","TTP488"],"crossReferences":{"drugbank":["DB12689"]},"linkedTargets":{"rows":["ENSG00000204305"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL418068","canonicalSmiles":"O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O","inchiKey":"FCDLCPWAQCPTKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RHEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rhein"],"crossReferences":{"PubChem":["124883454","124883455","144208296","17388745","50104142","855879"],"Wikipedia":["Rhein_(molecule)"],"drugbank":["DB13174"],"chEBI":["8825"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4211107","canonicalSmiles":"COc1ccc2cc(C(C)C(=O)Oc3ccc(C(N)=S)cc3)ccc2c1","inchiKey":"YCNMAPLPQYQJFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATB-346","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atb-346"],"crossReferences":{"drugbank":["DB15377"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL428496","canonicalSmiles":"COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O","inchiKey":"QDLHCMPXEPAAMD-QAIWCSMKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WORTMANNIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Wortmannin"],"crossReferences":{"PubChem":["130227","26756872","92763426"],"Wikipedia":["Wortmannin"],"drugbank":["DB08059"],"chEBI":["52289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297335","drugType":"Small molecule","blackBoxWarning":false,"name":"PSMA-HBED-CC GA-68","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4300153","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gallium ga 68 psma-11"],"synonyms":["(68ga)hbed-psma","(68ga)psma-hbed-cc","68ga-psma-11","68ga-psma-hbed-cc","DKFZ-PSMA-11 GA-68","Ga-68 psma-11","Ga-68-labeled psma-11","Ga-psma-hbed-cc ga-68","Gallium (68ga) gozetotide","Gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc","Gallium ga-68 gozetotide","Gallium ga-68 psma-11","Gallium gozetotide ga-68","Glu-urea-lys(ahx)-hbed-cc ga-68","Prostamedix","Psma-11 ga 68","Psma-11 ga-68","Psma-hbed-cc ga-68"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and has 1 investigational indication."}
{"id":"CHEMBL4297391","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]([C@H](C=O)NC(C)=O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@H](O)CO)C(N)=O)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"DNUXJWBKTMJNEP-JVSLBXKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DISACCHARIDE TRIPEPTIDE GLYCEROL DIPALMITOYL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Disaccharide tripeptide glycerol dipalmitoyl","Dtp-gdp","Immther"],"crossReferences":{"drugbank":["DB15423"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297534","canonicalSmiles":"CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1.O=C(O)/C=C\\C(=O)O","inchiKey":"VJCVKWFBWAVYOC-UIXXXISESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GLASDEGIB MALEATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2043437","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daurismo"],"synonyms":["Glasdegib maleate","PF-04449913 MALEATE"],"crossReferences":{"DailyMed":["glasdegib%20maleate"]},"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for acute myeloid leukemia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297673","canonicalSmiles":"CN(CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1)C(=O)CNC(=O)CN.Cl","inchiKey":"ZRZLEMQBDKNTLJ-UHFFFAOYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRORILUZOLE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4297586","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BHV-4157","BHV-4157 HYDROCHLORIDE","Bhv-4157","Troriluzole hydrochloride"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297719","drugType":"Unknown","blackBoxWarning":false,"name":"CDX-014","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-014","CDX-014-VCMMAE","CR014-VC-MMAE","Cdx 014","Cdx-014"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297730","drugType":"Antibody","blackBoxWarning":false,"name":"CONCIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-TFPI","Concizumab","MAB-2021","NN-7415","NN7415","NNC 0172-0000-2021","NNC-0172-0000-2021","mAb2021"],"linkedTargets":{"rows":["ENSG00000003436"],"count":1},"linkedDiseases":{"rows":["Orphanet_98879","Orphanet_98878"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297901","drugType":"Unknown","blackBoxWarning":false,"name":"AZD-5312","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 5312","Azd-5312","Azd5312","ISIS-ARRX","ISIS-AZ1RX"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297997","drugType":"Antibody","blackBoxWarning":false,"name":"IODINE I 131 APAMISTAMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apamistamab iodine i-131","I 131 moab bc8","I-131 moab bc8","I-131-BC8","Iodine (131i) apamistamab","Iodine i 131 apamistamab","Iodine i-131 apamistamab","Iomab-B","Iomab-b"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298028","drugType":"Antibody","blackBoxWarning":false,"name":"TAVOLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-0562","MEDI0562","Medi 0562","Medi0562","Tavolimab","Tavolixizumab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4303288","canonicalSmiles":"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O","inchiKey":"WMHSRBZIJNQHKT-FFKFEZPRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ABACAVIR SULFATE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1380","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abacavir sulfate","Ziagen"],"synonyms":["1592U89","1592U89 SULFATE","Abacavir (as sulfate)","Abacavir hemisulfate","Abacavir sulfate","Abacavir sulfate racemic","Abacavir sulphate","Abacaviri sulfas","Abamune","DRG-0257","NSC-760063"],"crossReferences":{"DailyMed":["abacavir%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for immunodeficiency disease and hiv infection and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL445472","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]1C[C@@H](Br)C2=O","inchiKey":"CWVMWSZEMZOUPC-JUAXIXHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"16.ALPHA.-BROMOEPIANDROSTERONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["16.alpha.-bromoepiandrosterone","HE-2000","HE2000","He2000"],"crossReferences":{"drugbank":["DB05107"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL446","canonicalSmiles":"Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1","inchiKey":"ASWVTGNCAZCNNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETHAZINE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Smz-Med 454","Sulfamezathine ('s-mez')"],"synonyms":["BN-2409","NSC-67457","NSC-683529","Sulfadimerazine","Sulfadimethylpyrimidine","Sulfadimidine","Sulfadimidinum","Sulfamethazine","Sulfamethazine (trisulfapyrimidines)","Sulfamezathine","Sulfamidine"],"crossReferences":{"PubChem":["124883543","144204398","144209419","144213323","170464893","17389727","26751451","7969855","855573"],"Wikipedia":["Sulfadimidine"],"drugbank":["DB01582"],"chEBI":["102265"]},"childChemblIds":["CHEMBL1563050"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949 and is indicated for bacterial disease."}
{"id":"CHEMBL4594400","canonicalSmiles":"Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1","inchiKey":"RYBLECYFLJXEJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUMETINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glumetinib","Sc-c244","Scc244"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460901","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@@H]2O)c(=O)[nH]1","inchiKey":"FOGRQMPFHUHIGU-PXBUCIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Arabinouridine 3'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arabinouridine 3'-Phosphate"],"crossReferences":{"drugbank":["DB02805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650273","canonicalSmiles":"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](C)NC1=O.CC(=O)O.CC(=O)O","inchiKey":"GOOYENKUPOAYOV-KMKYJKQVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SETMELANOTIDE ACETATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3301624","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imcivree"],"synonyms":["Setmelanotide acetate"],"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for obesity."}
{"id":"CHEMBL4650340","canonicalSmiles":"O=C(O)c1cccc(CN2CN(C3CCCCC3)C3(CCN(CCCC(=O)c4ccccc4)CC3)C2=O)c1","inchiKey":"BDXJYAAYLZTLEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAZPIROBEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-906","TAK906","Tak-906","Trazpiroben"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL465161","canonicalSmiles":"C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@]36[C@@H](OC(=O)[C@@H]6O)O[C@@]4(C(=O)O5)[C@]21O","inchiKey":"FPUXKXIZEIDQKW-VKMVSBOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINKGOLIDE A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49664997"],"drugbank":["DB06743"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL482193","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccccc2)n2ncc(C(C)C)c2n1","inchiKey":"SQUNOCMDMIQIQK-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL482193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08285"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL496978","canonicalSmiles":"O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNCc1ccc([123I])cc1)C(=O)O)C(=O)O","inchiKey":"OXUUJYOSVPMNKP-ZANJDRPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOFOLASTAT I 123","maximumClinicalTrialPhase":0,"parentId":"CHEMBL496748","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Trofex"],"synonyms":["123-i-mip-1072","Iofolastat ((sup 123)i)","Iofolastat (123 i)","Iofolastat (123-i)","Iofolastat (123i)","Iofolastat i 123","Iofolastat i-123","MIP 1072","MIP-1072"],"crossReferences":{"drugbank":["DB12514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL498847","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CC(C)O","inchiKey":"KPQZUUQMTUIKBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SECNIDAZOLE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deprozol","Flagentyl","Sabima","Secnol","Solosec"],"synonyms":["NSC-759812","Ornidazole metabolite m4","PM-185184","RP 14539","RP-14539","SYM-1219","Secnidal","Secnidazole","Secnidazole anhydrous"],"crossReferences":{"DailyMed":["secnidazole"],"PubChem":["144205010","14742762","170466630","174007190","26719698","50086443"],"Wikipedia":["Secnidazole"],"drugbank":["DB12834"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL504888","canonicalSmiles":"COP(N)(=O)SC","inchiKey":"NNKVPIKMPCQWCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAMIDOPHOS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209448","144211057","26753687","26753688"],"Wikipedia":["Methamidophos"],"drugbank":["DB14972"],"chEBI":["38721"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL50894","canonicalSmiles":"O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1","inchiKey":"OLUKILHGKRVDCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALSTERPAULLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alsterpaullone"],"crossReferences":{"PubChem":["103905621","528841","92764452"],"drugbank":["DB04014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL517","canonicalSmiles":"CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C","inchiKey":"UVTNFZQICZKOEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DISOPYRAMIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(rs)-disopyramide","Dicorantil","Disopyramide","Dl-disopyramide","H-3292","Isorythm","Lispine","Norpace","Ritmilen","Rythmodan p","SC-7031","Searle-703"],"crossReferences":{"DailyMed":["disopyramide%20phosphate"],"PubChem":["144204278","170464947","174006632","50106174","85148360","85231006","90340571","90341382"],"TG-GATEs":["102"],"Wikipedia":["Disopyramide"],"drugbank":["DB00280"],"chEBI":["4657"]},"childChemblIds":["CHEMBL1201020"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0003144","HP_0004308"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for ventricular arrhythmia and cardiac arrhythmia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL521203","canonicalSmiles":"CCn1ncc2c(NC3CCOCC3)c(C(=O)NCc3ccccc3)cnc21","inchiKey":"QZGJNFBMYYEFGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL521203","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06909"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL526479","canonicalSmiles":"O/N=C1\\CCc2cc(-c3cn(C4CCNCC4)nc3-c3ccncc3)ccc21","inchiKey":"KWEFZSZCLBHIEQ-YYADALCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL526479","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08553"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL540929","canonicalSmiles":"Cc1nnc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)o1","inchiKey":"HCSFWJQLIPWUFZ-JAJWTYFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL540929","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03354"],"chEBI":["44722"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL549386","canonicalSmiles":"CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O","inchiKey":"YAKWPXVTIGTRJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOTEMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fotemustine","Muphoran","Mustophorane","S 10036","S-10036","S10036"],"crossReferences":{"PubChem":["174007311"],"Wikipedia":["Fotemustine"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL570015","canonicalSmiles":"COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1","inchiKey":"JFHROPTYMMSOLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-256066","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK256066","Gsk-256066"],"crossReferences":{"drugbank":["DB12137"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL572878","canonicalSmiles":"Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1","inchiKey":"GCIKSSRWRFVXBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOZASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-045","MK-0457","Tozasertib","VX-68","VX-680"],"crossReferences":{"PubChem":["103905648","137275826","162108261","164339430","49645761","50100121"]},"childChemblIds":["CHEMBL2105657"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000198","EFO_0000339","EFO_0000220","EFO_0004289","EFO_0003060","EFO_1001951","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL577144","canonicalSmiles":"O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CCO[C@H]2COC1=NS(=O)(=O)c2ccccc21","inchiKey":"MDYIGSPVMWSFEZ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL577144","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02827"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL595439","canonicalSmiles":"O=C1NC(=O)[C@]2(N1)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O","inchiKey":"QRXBDPYWCAAAAI-UXDJRKLDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL595439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01823"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL64195","canonicalSmiles":"O=C(CCCl)NCc1ccccc1","inchiKey":"JPYQFYIEOUVJDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECLAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neuracen","Nydrane"],"synonyms":["Beclamide","Benzchlorpropamide","Benzylamide","NSC-67062"],"crossReferences":{"PubChem":["170466371"],"Wikipedia":["Beclamide"],"drugbank":["DB09011"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for epilepsy."}
{"id":"CHEMBL71360","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CCN(C)CCOP(=O)(O)OP(=O)(O)O","inchiKey":"OEMBPHBKZPOPBN-NWLVNBMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL71360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08180"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL770","canonicalSmiles":"c1ccc(CC2=NCCN2)cc1","inchiKey":"JIVZKJJQOZQXQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLAZOLINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-35110","Priscoline","Tolazine","Tolazoline"],"crossReferences":{"PubChem":["11112156"],"Wikipedia":["Tolazoline"],"drugbank":["DB00797"],"chEBI":["28502"]},"childChemblIds":["CHEMBL1689"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000113749","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000196639","ENSG00000150594"],"count":8},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved indications."}
{"id":"CHEMBL7890","canonicalSmiles":"COC(=O)[C@@H](N)CCCNC(=N)N[N+](=O)[O-]","inchiKey":"KCWZGJVSDFYRIX-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-NAME","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-name","Ng-nitro-l-arginine methyl ester"],"crossReferences":{"PubChem":["11113631","144204471","170466867","26751830","26751831","50104533","90340714"],"drugbank":["DB12750"],"chEBI":["7549"]},"childChemblIds":["CHEMBL1256014"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL829","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2Sc2ccccc21","inchiKey":"ZZHLYYDVIOPZBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPROMAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alimemazine","BAYER-1219","Dl-trimeprazine","Methylpromazine","RP-6549","Temaril","Trimeprazine"],"crossReferences":{"Wikipedia":["Alimemazine"],"drugbank":["DB01246"],"chEBI":["9725"]},"childChemblIds":["CHEMBL3989885","CHEMBL4785767","CHEMBL1713082"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergic disease."}
{"id":"CHEMBL84158","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC","inchiKey":"JTVPZMFULRWINT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-758225","Tiapride"],"crossReferences":{"PubChem":["11111853","11111854"],"Wikipedia":["Tiapride"],"drugbank":["DB13025"]},"childChemblIds":["CHEMBL1256772"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000151577"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","Orphanet_399","MONDO_0002050","HP_0000726","EFO_0004895","EFO_0005407","EFO_0005230"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL86658","canonicalSmiles":"CCO[C@@H](Cc1ccc(OCCn2c3ccccc3c3ccccc32)cc1)C(=O)O","inchiKey":"WUZIMDSVRIBNNI-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL86658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04270"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL89598","canonicalSmiles":"C=CC(N)CCC(=O)O","inchiKey":"PJDFLNIOAUIZSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VIGABATRIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sabril"],"synonyms":["5-hexenoic acid, 4-amino-","CPP-109","Gamma vinyl gaba","Gamma-vinyl gaba","MDL 71,754","MDL-71754","RMI-71754","Vigabatrin","Vinyl gamma-aminobutyric acid"],"crossReferences":{"DailyMed":["vigabatrin"],"PubChem":["104171263","144203852","26747129","26751903","50104581","50104582","50104583","85231284","90340732"],"Wikipedia":["Vigabatrin"],"drugbank":["DB01080"],"chEBI":["63638"]},"childChemblIds":["CHEMBL4303352"],"linkedTargets":{"rows":["ENSG00000183044"],"count":1},"linkedDiseases":{"rows":["EFO_1000877","EFO_0002610","EFO_0000474","Orphanet_3451","EFO_0004895","Orphanet_805","EFO_0004701","MONDO_0007079","MONDO_0100062","EFO_0001073","HP_0002384"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 4 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL96433","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3O)cc2c1","inchiKey":"GAVRMVQHHVMXFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL96433","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03159"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
